Colorectal Cancer Clinical Trial Using FOLFIRI regimen, bevacizumab and mFOLFOX6

- The folks at Genentech are studying the effects of bevacizumab; FOLFIRI regimen; mFOLFOX6 on Colorectal Cancer in individuals ages 18 years and older. This clinical trial is slated to start August 2011 and is expected to end circa January 2015.

888-662-6728 (U.S. Only)
Reference Study ID Number: ML25710 www.roche.com/about_roche/roche_worldwide.htm
Overall Study Contact Info
StatusName Contact Phone
RecruitingReference Study ID Number: ML25710 www.roche.com/about_roche/roche_worldwide.htmglobal.rochegenentechtrials@roche.com888-662-6728 (U.S. Only)

This study is officially titled, "A Randomized Phase II Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Cancer."

Locations

Houston, Texas - Active, not recruiting

Pittsburgh, Pennsylvania - Recruiting

Corpus Christi, Texas - Active, not recruiting

Charleston, South Carolina - Completed

Philadelphia, Pennsylvania - Active, not recruiting

Dunmore, Pennsylvania - Recruiting

Media, Pennsylvania - Active, not recruiting

Oklahoma City, Oklahoma - Active, not recruiting

Toledo, Ohio - Active, not recruiting

Columbus, Ohio - Active, not recruiting

Durham, North Carolina - Active, not recruiting

Winston-salem, North Carolina - Active, not recruiting

Washington, North Carolina - Completed

High Point, North Carolina - Active, not recruiting

Greensboro, North Carolina - Active, not recruiting

Rochester, New York - Active, not recruiting

Lake Success, New York - Active, not recruiting

Las Cruces, New Mexico - Active, not recruiting

Santa Fe, New Mexico - Active, not recruiting

Albuquerque, New Mexico - Suspended

Farmington, New Mexico - Active, not recruiting

Albuquerque, New Mexico - Active, not recruiting

Albuquerque, New Mexico - Active, not recruiting

Cherry Hill, New Jersey - Active, not recruiting

Lincoln, Nebraska - Active, not recruiting

Burlington, Massachusetts - Completed

Billings, Montana - Completed

Scarborough, Maine - Active, not recruiting

Louisville, Kentucky - Active, not recruiting

Fairway, Kansas - Recruiting

Terre Haute, Indiana - Active, not recruiting

Indianapolis, Indiana - Active, not recruiting

Goshen, Indiana - Active, not recruiting

Peoria, Illinois - Active, not recruiting

Maywood, Illinois - Completed

Joliet, Illinois - Active, not recruiting

Boise, Idaho - Active, not recruiting

Port Saint Lucie, Florida - Active, not recruiting

Miami, Florida - Active, not recruiting

Jacksonville, Florida - Active, not recruiting

Hollywood, Florida - Completed

Trumbull, Connecticut - Active, not recruiting

Stamford, Connecticut - Completed

Denver, Colorado - Active, not recruiting

Walnut Creek, California - Active, not recruiting

Vallejo, California - Active, not recruiting

South San Francisco, California - Active, not recruiting

Santa Clara, California - Active, not recruiting

San Jose, California - Suspended

San Francisco, California - Completed

San Francisco, California - Suspended

Sacramento, California - Active, not recruiting

Sacramento, California - Active, not recruiting

Roseville, California - Active, not recruiting

Pleasant Hill, California - Active, not recruiting

Oakland, California - Suspended

Los Angeles, California - Terminated

Los Angeles, California - Active, not recruiting

Hayward, California - Active, not recruiting

Fresno, California - Active, not recruiting

Fountain Valley, California - Active, not recruiting

Duarte, California - Active, not recruiting

Bellflower, California - Active, not recruiting

Little Rock, Arkansas - Terminated

Birmingham, Alabama - Active, not recruiting

Madison, Wisconsin - Active, not recruiting

Wauwatosa, Wisconsin - Completed

Edmonton, Alberta - Recruiting

Tallinn, Estonia - Active, not recruiting

Tartu, Estonia - Active, not recruiting

Cork, Ireland - Active, not recruiting

Dublin, Ireland - Active, not recruiting

Galway, Ireland - Active, not recruiting

Oslo, Norway - Active, not recruiting

Coimbra, Portugal - Recruiting

Lisboa, Portugal - Recruiting

Porto, Portugal - Recruiting

Aarau, Switzerland - Active, not recruiting

Basel, Switzerland - Active, not recruiting

Luzern, Switzerland - Active, not recruiting

Zürich, Switzerland - Active, not recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.